Joachim Hombach

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Vaccines against dengue: a review of current candidate vaccines at advanced development stages
    Joachim Hombach
    World Health Organization, Initiative for Vaccine Research, Geneva, Switzerland
    Rev Panam Salud Publica 21:254-60. 2007
  2. pmc Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Raymond Hutubessy
    Initiative for Vaccine Research, Immunization, Biologicals and Vaccines Department, World Health Organization, 20 Avenue Appia, CH 1210 Geneva, Switzerland
    BMC Med 9:55. 2011
  3. pmc Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
    Nathorn Chaiyakunapruk
    Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    BMC Med 9:53. 2011
  4. pmc Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
    Susan Hills
    PATH, Seattle, WA, USA
    BMC Infect Dis 9:214. 2009
  5. doi request reprint Guidelines for clinical trials of dengue vaccine in endemic areas
    Joachim Hombach
    Initiative for Vaccine Research, Immunization, Vaccines and Biologicals, Family and Community Health, WHO, Geneva, Switzerland
    J Clin Virol 46:S7-9. 2009
  6. ncbi request reprint Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand
    J Hombach
    Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
    Vaccine 23:2689-95. 2005
  7. ncbi request reprint Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
    Joachim Hombach
    Immunization, Vaccines and Biologicals, World Health Organization, 20, Geneva 27, Switzerland
    Vaccine 23:5205-11. 2005
  8. ncbi request reprint Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005
    Joachim Hombach
    Initiative for Vaccine Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Vaccine 25:4130-9. 2007
  9. doi request reprint Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
    Adwoa D Bentsi-Enchill
    Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Vaccine 31:2603-9. 2013
  10. ncbi request reprint A global pandemic influenza vaccine action plan
    Marie Paule Kieny
    World Health Organization, Geneva, Switzerland
    Vaccine 24:6367-70. 2006

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Vaccines against dengue: a review of current candidate vaccines at advanced development stages
    Joachim Hombach
    World Health Organization, Initiative for Vaccine Research, Geneva, Switzerland
    Rev Panam Salud Publica 21:254-60. 2007
  2. pmc Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
    Raymond Hutubessy
    Initiative for Vaccine Research, Immunization, Biologicals and Vaccines Department, World Health Organization, 20 Avenue Appia, CH 1210 Geneva, Switzerland
    BMC Med 9:55. 2011
    ....
  3. pmc Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
    Nathorn Chaiyakunapruk
    Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    BMC Med 9:53. 2011
    ..With the aim to guide policymakers on their optimal use, we compared publicly available decision-making tools in relation to their methods, influential parameters and results...
  4. pmc Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
    Susan Hills
    PATH, Seattle, WA, USA
    BMC Infect Dis 9:214. 2009
    ..To aid acceptance of the Standards, we describe the process of development, provide the supporting evidence, and explain the rationale for the recommendations made in the document...
  5. doi request reprint Guidelines for clinical trials of dengue vaccine in endemic areas
    Joachim Hombach
    Initiative for Vaccine Research, Immunization, Vaccines and Biologicals, Family and Community Health, WHO, Geneva, Switzerland
    J Clin Virol 46:S7-9. 2009
    ..These guidelines are primarily aimed at national regulatory authorities, vaccine developers and research scientists and should be analysed, discussed and adjusted where necessary...
  6. ncbi request reprint Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand
    J Hombach
    Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
    Vaccine 23:2689-95. 2005
    ....
  7. ncbi request reprint Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
    Joachim Hombach
    Immunization, Vaccines and Biologicals, World Health Organization, 20, Geneva 27, Switzerland
    Vaccine 23:5205-11. 2005
    ..More detailed recommendations will be drafted following further consultations to serve as WHO guidelines for evaluation and licensure for new JE vaccines...
  8. ncbi request reprint Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005
    Joachim Hombach
    Initiative for Vaccine Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Vaccine 25:4130-9. 2007
    ..It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials...
  9. doi request reprint Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
    Adwoa D Bentsi-Enchill
    Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Vaccine 31:2603-9. 2013
    ..Careful planning and a coordinated approach to safety assessment are recommended to ensure adequate long-term evaluation of dengue vaccines that will support their introduction and continued use...
  10. ncbi request reprint A global pandemic influenza vaccine action plan
    Marie Paule Kieny
    World Health Organization, Geneva, Switzerland
    Vaccine 24:6367-70. 2006
    ..2) To strengthen the engagement and collaboration of key partners and stakeholders...
  11. ncbi request reprint Dengue
    A Kroeger
    Nat Rev Microbiol 2:360-1. 2004
  12. ncbi request reprint Dengue research and training supported through the World Health Organization
    A Kroeger
    UNICEF UNDP World Bank WHO Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 1211 Geneva 27, Switzerland
    Ann Trop Med Parasitol 100:S97-S101. 2006
    ..This intensified effort, in close collaboration with other stakeholders, is contributing towards the goals of reversing the current epidemiological trends and of reducing the global burden posed by dengue in all of its forms...
  13. doi request reprint Next generation dengue vaccines: a review of candidates in preclinical development
    Julia Schmitz
    Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
    Vaccine 29:7276-84. 2011
    ..This review provides an overview of the various technological approaches to dengue vaccine development and specifically focuses on candidates in preclinical development...
  14. ncbi request reprint Arguments for live flavivirus vaccines
    Joachim Hombach
    Lancet 364:498-9. 2004
  15. doi request reprint "Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation
    Robert Edelman
    Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA
    Vaccine 26:4113-9. 2008
    ....
  16. doi request reprint Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
    John T Roehrig
    National Center for Zoonotic, Vector Borne and Enteric Diseases, Centers for Disease Control and Prevention, U S Department of Health and Human Services, Fort Collins, Colorado, USA
    Viral Immunol 21:123-32. 2008
    ..A more complete version of these guidelines is available on the WHO website: http://www.who.int/immunization/documents/date/en/index.html...